Jeanny B Aragon-Ching

32PUBLICATIONS
83CO-AUTHORS
Bioavailability and ecotoxicologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 13, 2026
Transdermal estradiol (tE2) as an alternative androgen deprivation therapy (ADT) in locally advanced prostate cancer.

|Jul 11, 2026
Circulating tumor DNA (ctDNA)-guided adjuvant therapy for muscle-invasive bladder cancer (MIBC): ready for primetime?

|Feb 20, 2026
Same-Day Multidisciplinary Clinics for Patients With Newly Diagnosed Adult Solid Tumor Cancer: A Systematic Review.

John F Deeken, Wayne Pereanu, Raymond C Wadlow

|Jan 15, 2026
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Daniel R Carrizosa, Michael Rothe, Pam K Mangat

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

|Sep 15, 2025
Polygenic risk score (PRS) as prostate cancer screening: ready for primetime?

Jinny Park, Jeanny B Aragon-Ching

Pageof 6

Frequent Collaborators

3 joint publications

Ravi A Madan

3 joint publications

Eun-Mi Yu

2 joint publications

Thomas Powles

2 joint publications

Cora N Sternberg